vs
丹纳赫（DHR）与EMCOR Group, Inc.（EME）财务数据对比。点击上方公司名可切换其他公司
丹纳赫的季度营收约是EMCOR Group, Inc.的1.3倍（$6.0B vs $4.5B），丹纳赫净利率更高（17.3% vs 9.6%，领先7.7%），EMCOR Group, Inc.同比增速更快（19.7% vs 3.7%），丹纳赫自由现金流更多（$1.1B vs $492.5M），过去两年EMCOR Group, Inc.的营收复合增速更高（14.7% vs 1.8%）
丹纳赫是总部位于美国华盛顿特区的医疗健康企业，聚焦生物技术、生命科学与诊断领域的产品研发。公司下设三大业务板块：生物技术板块开发治疗相关产品，生命科学板块覆盖疾病溯源、新疗法研发、药物疫苗与基因编辑技术的测试生产，诊断板块研发检测仪器，为全球生命健康产业提供核心支持。
EMCOR Group Inc.是总部位于美国康涅狄格州诺沃克的综合服务企业，核心业务涵盖工程设计、建筑施工、不动产管理三大板块，可为各行业客户提供相关领域的专业定制化解决方案及全流程配套服务。
DHR vs EME — 直观对比
营收规模更大
DHR
是对方的1.3倍
$4.5B
营收增速更快
EME
高出16.1%
3.7%
净利率更高
DHR
高出7.7%
9.6%
自由现金流更多
DHR
多$592.5M
$492.5M
两年增速更快
EME
近两年复合增速
1.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.0B | $4.5B |
| 净利润 | $1.0B | $434.6M |
| 毛利率 | 60.3% | 19.7% |
| 营业利润率 | 22.6% | 12.7% |
| 净利率 | 17.3% | 9.6% |
| 营收同比 | 3.7% | 19.7% |
| 净利润同比 | 7.9% | 48.8% |
| 每股收益（稀释后） | $1.45 | $9.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHREME
| Q1 26 | $6.0B | — | ||
| Q4 25 | $6.8B | $4.5B | ||
| Q3 25 | $6.1B | $4.3B | ||
| Q2 25 | $5.9B | $4.3B | ||
| Q1 25 | $5.7B | $3.9B | ||
| Q4 24 | $6.5B | $3.8B | ||
| Q3 24 | $5.8B | $3.7B | ||
| Q2 24 | $5.7B | $3.7B |
净利润DHREME
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.2B | $434.6M | ||
| Q3 25 | $908.0M | $295.4M | ||
| Q2 25 | $555.0M | $302.2M | ||
| Q1 25 | $954.0M | $240.7M | ||
| Q4 24 | $1.1B | $292.2M | ||
| Q3 24 | $818.0M | $270.3M | ||
| Q2 24 | $907.0M | $247.6M |
毛利率DHREME
| Q1 26 | 60.3% | — | ||
| Q4 25 | 58.0% | 19.7% | ||
| Q3 25 | 58.2% | 19.4% | ||
| Q2 25 | 59.3% | 19.4% | ||
| Q1 25 | 61.2% | 18.7% | ||
| Q4 24 | 59.5% | 20.1% | ||
| Q3 24 | 58.7% | 19.9% | ||
| Q2 24 | 59.7% | 18.7% |
营业利润率DHREME
| Q1 26 | 22.6% | — | ||
| Q4 25 | 22.0% | 12.7% | ||
| Q3 25 | 19.1% | 9.4% | ||
| Q2 25 | 12.8% | 9.6% | ||
| Q1 25 | 22.2% | 8.2% | ||
| Q4 24 | 21.8% | 10.3% | ||
| Q3 24 | 16.5% | 9.8% | ||
| Q2 24 | 20.3% | 9.1% |
净利率DHREME
| Q1 26 | 17.3% | — | ||
| Q4 25 | 17.5% | 9.6% | ||
| Q3 25 | 15.0% | 6.9% | ||
| Q2 25 | 9.3% | 7.0% | ||
| Q1 25 | 16.6% | 6.2% | ||
| Q4 24 | 16.6% | 7.7% | ||
| Q3 24 | 14.1% | 7.3% | ||
| Q2 24 | 15.8% | 6.8% |
每股收益（稀释后）DHREME
| Q1 26 | $1.45 | — | ||
| Q4 25 | $1.69 | $9.64 | ||
| Q3 25 | $1.27 | $6.57 | ||
| Q2 25 | $0.77 | $6.72 | ||
| Q1 25 | $1.32 | $5.26 | ||
| Q4 24 | $1.50 | $6.30 | ||
| Q3 24 | $1.12 | $5.80 | ||
| Q2 24 | $1.22 | $5.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.1B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $3.7B |
| 总资产 | — | $9.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DHREME
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $655.1M | ||
| Q2 25 | — | $486.0M | ||
| Q1 25 | — | $576.7M | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $807.3M |
总债务DHREME
| Q1 26 | — | — | ||
| Q4 25 | $18.4B | — | ||
| Q3 25 | $16.9B | — | ||
| Q2 25 | $17.4B | — | ||
| Q1 25 | $16.5B | — | ||
| Q4 24 | $16.0B | — | ||
| Q3 24 | $17.5B | — | ||
| Q2 24 | $17.0B | — |
股东权益DHREME
| Q1 26 | — | — | ||
| Q4 25 | $52.5B | $3.7B | ||
| Q3 25 | $51.1B | $3.3B | ||
| Q2 25 | $52.3B | $3.1B | ||
| Q1 25 | $50.8B | $2.9B | ||
| Q4 24 | $49.5B | $2.9B | ||
| Q3 24 | $51.3B | $2.8B | ||
| Q2 24 | $49.9B | $2.7B |
总资产DHREME
| Q1 26 | — | — | ||
| Q4 25 | $83.5B | $9.3B | ||
| Q3 25 | $79.9B | $8.6B | ||
| Q2 25 | $81.6B | $8.4B | ||
| Q1 25 | $79.1B | $8.1B | ||
| Q4 24 | $77.5B | $7.7B | ||
| Q3 24 | $80.6B | $7.3B | ||
| Q2 24 | $78.6B | $7.1B |
负债/权益比DHREME
| Q1 26 | — | — | ||
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.33× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.32× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $524.4M |
| 自由现金流经营现金流 - 资本支出 | $1.1B | $492.5M |
| 自由现金流率自由现金流/营收 | 18.2% | 10.9% |
| 资本支出强度资本支出/营收 | 4.0% | 0.7% |
| 现金转化率经营现金流/净利润 | 1.28× | 1.21× |
| 过去12个月自由现金流最近4个季度 | $5.3B | $1.2B |
8季度趋势，按日历期对齐
经营现金流DHREME
| Q1 26 | $1.3B | — | ||
| Q4 25 | $2.1B | $524.4M | ||
| Q3 25 | $1.7B | $475.5M | ||
| Q2 25 | $1.3B | $193.7M | ||
| Q1 25 | $1.3B | $108.5M | ||
| Q4 24 | $2.0B | $469.5M | ||
| Q3 24 | $1.5B | $526.4M | ||
| Q2 24 | $1.4B | $279.7M |
自由现金流DHREME
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.7B | $492.5M | ||
| Q3 25 | $1.4B | $448.8M | ||
| Q2 25 | $1.1B | $165.6M | ||
| Q1 25 | $1.1B | $82.3M | ||
| Q4 24 | $1.5B | $451.8M | ||
| Q3 24 | $1.2B | $508.7M | ||
| Q2 24 | $1.1B | $260.4M |
自由现金流率DHREME
| Q1 26 | 18.2% | — | ||
| Q4 25 | 25.5% | 10.9% | ||
| Q3 25 | 22.6% | 10.4% | ||
| Q2 25 | 18.4% | 3.8% | ||
| Q1 25 | 18.4% | 2.1% | ||
| Q4 24 | 23.0% | 12.0% | ||
| Q3 24 | 21.0% | 13.8% | ||
| Q2 24 | 19.7% | 7.1% |
资本支出强度DHREME
| Q1 26 | 4.0% | — | ||
| Q4 25 | 5.4% | 0.7% | ||
| Q3 25 | 4.8% | 0.6% | ||
| Q2 25 | 4.2% | 0.7% | ||
| Q1 25 | 4.3% | 0.7% | ||
| Q4 24 | 7.9% | 0.5% | ||
| Q3 24 | 5.1% | 0.5% | ||
| Q2 24 | 5.0% | 0.5% |
现金转化率DHREME
| Q1 26 | 1.28× | — | ||
| Q4 25 | 1.77× | 1.21× | ||
| Q3 25 | 1.83× | 1.61× | ||
| Q2 25 | 2.41× | 0.64× | ||
| Q1 25 | 1.36× | 0.45× | ||
| Q4 24 | 1.86× | 1.61× | ||
| Q3 24 | 1.85× | 1.95× | ||
| Q2 24 | 1.56× | 1.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
